T&L Co. Ltd (340570.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · South Korea · ISIN KR7340570001

Price
23,300.00 KRW
Market cap
370.10 bn KRW
P/E (2025)
9.81
P/S (2025)
2.25
Dividend yield
3.22 %
Net margin
23.19 %
Return on equity (ROE)
18.93 %
Return on assets (ROA)
17.54 %

T&L Co. Ltd financials

Fiscal year20242025
Revenue174.89 bn KRW164.16 bn KRW
Gross profit75.49 bn KRW72.39 bn KRW
Operating income56.96 bn KRW46.35 bn KRW
EBIT62.31 bn KRW47.84 bn KRW
Net income46.41 bn KRW38.07 bn KRW
Diluted EPS – continuing operations5,749.19 KRW2,374.60 KRW

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About T&L Co. Ltd

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.